Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
2024 Raleigh Christmas Parade: A festive showcase of floats, bands and Santa Claus
Recommended
What's open and closed on Thanksgiving? Grocery and retail hours for 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Adma Biologics
(NQ:
ADMA
)
21.18
-0.12 (-0.56%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,107,830
Open
21.45
Bid (Size)
21.15 (1)
Ask (Size)
21.20 (3)
Prev. Close
21.30
Today's Range
20.88 - 21.48
52wk Range
3.600 - 23.64
Shares Outstanding
196,357,149
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
BioNTech Stock Got A IBD RS Rating Lift
November 14, 2024
A Relative Strength Rating upgrade for BioNTech ADR shows improving technical performance.
Via
Investor's Business Daily
ADMA BIOLOGICS ALERT: Bragar Eagel & Squire, P.C. is Investigating ADMA Biologics, Inc. on Behalf of ADMA Biologics Stockholders and Encourages Investors to Contact the Firm
November 12, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Performance
YTD
+365.49%
+365.49%
1 Month
+32.71%
+32.71%
3 Month
+21.31%
+21.31%
6 Month
+122.71%
+122.71%
1 Year
+434.85%
+434.85%
More News
Read More
While growth is established for NASDAQ:ADMA, the stock's valuation remains reasonable.
November 12, 2024
Via
Chartmill
Vericel Stock Sees RS Rating Shoot Higher
November 11, 2024
Via
Investor's Business Daily
Kirby McInerney LLP Reminds ADMA Biologics, Inc. (ADMA) Investors of Shareholder Investigation
November 09, 2024
From
Kirby McInerney LLP
Via
Business Wire
(ADMA) - Analyzing ADMA Biologics's Short Interest
October 22, 2024
Via
Benzinga
Key Takeaways From ADMA Biologics Analyst Ratings
October 14, 2024
Via
Benzinga
ADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business Update
November 07, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against ADMA Biologics, Inc. (ADMA)
November 05, 2024
From
Kirby McInerney LLP
Via
Business Wire
ADMA Investors Have Opportunity to Join ADMA Biologics, Inc. Fraud Investigation with the Schall Law Firm
November 05, 2024
From
The Schall Law Firm
Via
Business Wire
This Is What Whales Are Betting On ADMA Biologics
October 10, 2024
Via
Benzinga
IBD 50's Top Stock, ADMA Biologics, Crashes After Auditor Unexpectedly Resigns
October 10, 2024
Via
Investor's Business Daily
Buckle Up And Use Volitility To Your Advantage
November 03, 2024
Via
Talk Markets
What You Missed On Wall Street This Past Friday
November 03, 2024
Via
Talk Markets
Amazon Posts Upbeat Results, Joins Cardinal Health, Waters, Atlassian, Charter Communications, MasTec And Other Big Stocks Moving Higher On Friday
November 01, 2024
Via
Benzinga
ADMA Biologics, A Top 1% Stock, Skyrockets After Settling Its Accounting Debacle
November 01, 2024
Via
Investor's Business Daily
ADMA Biologics to Report Third Quarter 2024 Financial Results on November 7, 2024
October 29, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into ADMA Biologics Inc and Encourages Investors to Contact the Firm
October 29, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
ADMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into ADMA Biologics Inc and Encourages Investors to Contact the Firm
October 28, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Bragar Eagel & Squire, P.C. Is Investigating ADMA Biologics, Napco, and L&W and Encourages Investors to Contact the Firm
October 21, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
ADMA BIOLOGICS ALERT: Bragar Eagel & Squire, P.C. is Investigating ADMA Biologics, Inc. on Behalf of ADMA Biologics Stockholders and Encourages Investors to Contact the Firm
October 15, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Amphastar Casts Wide Net, Hauls In Profits, Gets Rating Upgrade
October 15, 2024
Via
Investor's Business Daily
Alkermes Stock Jumps Nearly 30% In 3 Months Amid Hefty Profits
October 14, 2024
Via
Investor's Business Daily
CVS Has 'Real Value,' Jim Cramer Says: Micron Had An 'Amazing' Quarter
October 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 10, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.